Search Results - "Cascavilla, N."

Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma by Palumbo, A., Gay, F., Bringhen, S., Falcone, A., Pescosta, N., Callea, V., Caravita, T., Morabito, F., Magarotto, V., Ruggeri, M., Avonto, I., Musto, P., Cascavilla, N., Bruno, B., Boccadoro, M.

“…Bortezomib has shown significant activity in myeloma. In this multicenter trial, we assessed for the first time the combination of bortezomib, doxorubicin and…”
Get full text

Daratumumab plus bortezomib or daratumumab plus lenalidomide as salvage therapy for patients with myeloma: initial follow-up of an Italian multicentre retrospective clinical experience by ‘Rete Ematologica Pugliese’ by Mele, G., Cascavilla, N., Di Renzo, N., Guarini, A., Mazza, P., Melillo, L., Pavone, V., Tarantini, G., Curci, P., Falcone, A. P., Germano, C., Mele, A., Palazzo, G., Palumbo, G., Reddiconto, G., Rossini, B., Specchia, G., Musto, P., Pastore, D.

“…We report herein a multicentre retrospective analysis of 192 consecutive patients with symptomatic refractory/relapsed multiple myeloma (RRMM) treated with…”
Get full text

Bendamustine in combination with Ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial by Cortelezzi, A, Sciumè, M, Liberati, A M, Vincenti, D, Cuneo, A, Reda, G, Laurenti, L, Zaja, F, Marasca, R, Chiarenza, A, Gritti, G, Orsucci, L, Storti, S, Angelucci, E, Cascavilla, N, Gobbi, M, Mauro, F R, Morabito, F, Fabris, S, Piciocchi, A, Vignetti, M, Neri, A, Rossi, D, Giannarelli, D, Guarini, A, Foà, R

“…We conducted a phase II, noncomparative, open-label, multicenter GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) study (CLL0809) to assess the…”
Get full text

Primary Mediastinal B‐cell Lymphoma, a nationwide real‐life retrospective study from Fondazione Italiana Linfomi (FIL) by Iannitto, E., Balzarotti, M., Martelli, M., Zinzani, P., Tucci, A., Di Rocco, A., Cavallo, F., Usai, S. V., Guidetti, A., Ravano, E., Merli, F., Botto, B., Pelosini, M., Tecchio, C., Spina, M., Derenzini, E., Finotto, S., Mola, B., Pinto, A., Zanni, E., Battistini, R., Hohaus, S., Dogliotti, I., Gini, G., Zilioli, V. R., Lorenzo, S., Dodero, A., Broccoli, A., Maggi, A., Mannarella, C., Chiarenza, A., Pastore, D., Cascavilla, N., Musto, P., Stelitano, C., Di Raimondo, F., Di Renzo, N., Liberati, A. M., Salerno, M., Scalone, R., Nassi, L., Patti, C., Polizzi, V., Guarini, A., Amato, G., Ciccone, G., Evangelista, A., Lo Presti, F., La Porta, A., Mannina, D., Calogero, R. D., Musso, M., Consoli, U.

Get full text

BRENTUXIMAB VEDOTIN PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION IN HODGKIN'S LYMPHOMAS: A RETROSPECTIVE EXPERIENCE BY THE RETE EMATOLOGICA PUGLIESE (REP) by Gaudio, F., Mazza, P., Mele, A., Palazzo, G., Carella, A., Pastore, D., Cascavilla, N., Pavone, V., Specchia, G.

Get full text

Successful treatment of Schnitzler's syndrome with anakinra after failure of rituximab trial by Cascavilla, N, Bisceglia, M, D'Arena, G

“…We report a 50-year-old man who presented with a 5-year history of an intermittent widespread pruritic urticarioid rash and fever, fatigue, arthralgia and a…”
Get more information

Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy by Cavallo, F, Bringhen, S, Milone, G, Ben-Yehuda, D, Nagler, A, Calabrese, E, Cascavilla, N, Montefusco, V, Lupo, B, Liberati, A M, Crippa, C, Rossini, F, Passera, R, Patriarca, F, Cafro, A M, Omedè, P, Carella, A M, Peccatori, J, Catalano, L, Caravita, T, Musto, P, Petrucci, M T, Boccadoro, M, Palumbo, A

“…Lenalidomide has raised concerns regarding its potential impact on the ability to collect stem cells for autologous stem cell transplantation, especially after…”
Get full text

P18: DARATUMUMAB (D) PLUS BORTEZOMIB (V) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY/RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW‐UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY “RETE EMATOLOGICA PUGLIESE” by Mele, G, Cascavilla, N, Di Renzo, N, Guarini, A, Mazza, P, Melillo, L, Pavone, V, Tarantini, G, Curci, P, Falcone, AP, Germano, C, Mele, A, Palazzo, G, Palumbo, G, Reddiconto, G, Rossini, B, Specchia, G, Musto, P, Pastore, D

Get full text

P17: DARATUMUMAB (D) PLUS LENALIDOMIDE (R) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY‐RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW‐UP OF AN ITALIAN MULTICENTER RETROSPECTIVE CLINICAL EXPERIENCE BY “RETE EMATOLOGICA PUGLIESE” by Mele, G, Cascavilla, N, Di Renzo, N, Guarini, A, Mazza, P, Melillo, L, Pavone, V, Tarantini, G, Curci, P, Falcone, AP, Germano, C, Mele, A, Palazzo, G, Palumbo, G, Reddiconto, G, Rossini, B, Specchia, G, Musto, P, Pastore, D

Get full text

PB2016: COMPARISON BETWEEN DRD VS KRD AS SALVAGE THERAPY FOR MULTIPLE MYELOMA PATIENTS IN FIRST RELAPSE: THE REAL LIFE EXPERIENCE OF RETE EMATOLOGICA PUGLIESE (REP) by Mele, A., Prete, E., Citiso, S., Mele, G., Pastore, D., Sgherza, N., Curci, P., Musto, P., Falcone, A. P., Cascavilla, N., Germano, C., Giuseppe, T., Reddiconto, G., Di Renzo, N., Palazzo, G., Mazza, P., Rossini, B., Guarini, A., Palumbo, G., Melillo, L. M. A., Pavone, V.

Get full text

P564: FINAL RESULTS OF THE QOLESS AZA‐AMLE RANDOMIZED TRIAL TO EVALUATE THE EFFICACY OF 5‐AZA FOR POST‐REMISSION THERAPY OF ACUTE MYELOID LEUKEMIA IN ELDERLY PATIENTS by Oliva, E. N., Salutari, P., Di Raimondo, F., Reda, G., Capelli, D., Iannì, G., Tripepi, G., Alati, C., Mammì, C., D'Errigo, M. G., Niscola, P., Selleri, C., Musto, P., Vigna, E., Volpe, A., Cascavilla, N., Cannatà, M. C., Mannina, D., Candoni, A.

Get full text

P1084: CHECK‐POINT INHIBITORS IN PATIENTS WITH RELAPSE/REFRACTORY HODGKIN'S LYMPHOMA: A RETROSPECTIVE ANALYSYS BY THE RETE EMATOLOGICA PUGLIESE (REP) by Gaudio, F., Loseto, G., Bozzoli, V., Scalzulli, P. R., Mazzone, A. M., Tonialini, L., Fesce, V., Quintana, G., De santis, G., Masciopinto, P., Arcuti, E., Clemente, F., Scardino, S., Tarantini, G., Pastore, D., Melillo, L., Pavone, V., Mazza, P., Carella, A. M., Cascavilla, N., Di Renzo, N., Guarini, A., Musto, P.

Get full text

P1245: CLINICAL IMPACT OF IMMUNOGLOBULIN HEAVY CHAIN REPERTOIRE IN MANTLE CELL LYMPHOMA: A STUDY FROM THE FONDAZIONE ITALIANA LINFOMI (FIL) PHASE III MCL0208 TRIAL by Alessandria, B., Genuardi, E., Civita, A. M., Drandi, D., Mantoan, B., Ferrante, M., Borriero, M., Ragaini, S., Bondielli, G., Zaccaria, G. M., Barbero, D., Peri, V., Hohaus, S., Musuraca, G., Cascavilla, N., Ghiggi, C., Tani, M., Gaidano, G., Volpetti, S., Usai, S. V., Di Renzo, N., Cortelazzo, S., Ladetto, M., Ferrero, S.

Get full text

Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study by Musso, M, Scalone, R, Marcacci, G, Lanza, F, Di Renzo, N, Cascavilla, N, Di Bartolomeo, P, Crescimanno, A, Perrone, T, Pinto, A

“…BEAM is a widely used conditioning regimen for relapsed/refractory lymphoma patients undergoing auto-SCT. We conducted a multicenter study with an alternative…”
Get full text

Chronic lymphocytic leukemia-associated pure red cell aplasia by D'Arena, G, Cascavilla, N

“…Pure red cell aplasia (PRCA) is a well-known marrow failure which may be acquired or constitutional/congenital, as the Diamond-Blackfan syndrome. Acquired PRCA…”
Get more information

PB1984: ELOTUZUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED 3‐YEAR FOLLOW‐UP OF AN ITALIAN, MULTICENTER, EXPERIENCE OUTSIDE OF CONTROLLED CLINICAL TRIALS by Bruzzese, A., Derudas, D., Galli, M., Martino, E. A., Rocco, S., Conticello, C., Califano, C., Giuliani, N., Mangicavalli, S., Farina, G., Lombardo, A., Brunori, M., Rossi, E., Antonioli, E., Ria, R., Zambello, R., Di Renzo, N., Mele, G., Marcacci, G., Pietrantuono, G., Palumbo, G., Cascavilla, N., Cerchione, C., Belotti, A., Criscuolo, C., Uccello, G., Curci, P., Vigna, E., Mendicino, F., Iaccino, E., Mimmi, S., Botta, C., Vincelli, D., Sgherza, N., Bonalumi, A., Cupelli, L., Stocchi, R., Martino, M., Ballanti, S., Gangemi, D., Gagliardi, A., Gamberi, B., Pompa, A., Tripepi, G., Frigeri, F., Consoli, U., Bringhen, S., Zamagni, E., Patriarca, F., De Stefano, V., Di Raimondo, F., Palmieri, S., Petrucci, M. T., Offidani, M., Musto, P., Boccadoro, M., Cavo, M., Neri, A., Morabito, F., Gentile, M.

Get full text

“Real world” outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: Extended follow-up of a retrospective multicenter study by the “rete ematologica pugliese” by Mele, G, Melpignano, A, Quarta, G, Palumbo, G, Capalbo, S, Falcone, A, Cascavilla, N, Palazzo, G, Mazza, P, Iannitto, E, Curci, P, Rizzi, R, Specchia, G, Rossini, B, Pavone, V, Ria, R, Vacca, A, Buquicchio, C, Tarantini, G, Minoia, C, Guarini, A, Ditonno, P, Polimeno, G, Reddiconto, G, Di Renzo, N

“…Highlights • Study included patients excluded from trials because of unfavorable characteristics. • 246 were evaluable for response and toxicity: 68% had…”
Get full text

Lenalidomide and low-dose dexamethasone for newly diagnosed primary plasma cell leukemia by Musto, P, Simeon, V, Martorelli, M C, Petrucci, M T, Cascavilla, N, Di Raimondo, F, Caravita, T, Morabito, F, Offidani, M, Olivieri, A, Benevolo, G, Mina, R, Guariglia, R, D'Arena, G, Mansueto, G, Filardi, N, Nobile, F, Levi, A, Falcone, A, Cavalli, M, Pietrantuono, G, Villani, O, Bringhen, S, Omedè, P, Lerose, R, Agnelli, L, Todoerti, K, Neri, A, Boccadoro, M, Palumbo, A

Get full text

Monoclonal antibodies to treat graft-versus-host disease by Carella, A M, D'Arena, G, Cascavilla, N

“…To date, Graft-versus-host disease (GVHD) represents one of the most important complications of allogeneic hematopoietic stem cell transplantation (HSCT). GVHD…”
Get more information

Rituximab for allo-SCT-associated thrombotic thrombocytopenic purpura by Carella, A M, D'Arena, G, Greco, M M, Nobile, M, Cascavilla, N

Get full text